bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version founders capital partners  call   select page angel investors on the central coast individuals who invest in earlystage technologybased businesses on california central coast angel investors on the central coast individuals who invest in earlystage technologybased businesses on california central coast angel investors on the central coast individuals who invest in earlystage technologybased businesses on california central coast first investors beyond friends and family founders capital partners fcp is a group of “angel investors” – individuals who invest in earlystage technologybased businesses we tend to be the first investors beyond “friends and family” if traditional venture firms have already invested it is generally too late for us to become involved we are a group of some  individual investors – active and retired entrepreneurs executives industrial and academic scientists and engineers all are accredited investors participation by individuals in any given project is their own decision based on their interests and their perception of riskreward  investment size the size of our investments historically has ranged from a low of  to a high of  million our “sweet spot” is   industrial products and services our focus is industrial products and services we do not invest in consumer or fashion businesses  central coast region of california investment activity is focused principally but not exclusively in the central coast region of california the managing partner is l robert johnson bob is the point man for investment activity other individuals get involved based on their own interests but this is generally limited to being available for specific advice where they have relevant experience or expertise the size of our investments historically has ranged from a low of  to a high of  million our “sweet spot” is  primary areas of interest include using  software the internet mobile technologies and domain expertise to provide business and healthcare services and  sensor electronic and mechanical technologies applied to life sciences imaging monitoring and similar industrial applications our focus is industrial products and services we do not invest in consumer or fashion businesses investment activity is focused principally in the central coast region of california we are usually involved as an uncompensated adviser to any company we invest in this includes board representation advice on building the management team financing strategy and business and personnel problems in general because of our continuing active involvement we are limited as to how many companies we can work with at any given time as a practical matter we seem to do one deal a year in recent times we have participated with some of our individual investors who have started new companies outside our geographical area in these situations we are a passive investor if you have a project you would like to discuss send us an email contact us microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft home skip to main content founders capital management inchouston texas homeour callinga sense of purposeadherence to disciplinevalues and integritycommunicationscontact us  at founders capital management inc we construct monitor and maintain investment portfolios for a limited number of wealthy families our clients have achieved a measure of success in a variety of professional and business fields being successful they recognize that accumulating wealth is vastly different from managing wealth they engage us precisely because of our objective advice and consistent style and method we specialize in discretionary portfolio management by investing in a wide variety of securities our founding principles guide our everyday work from investment philosophy and security selection to client service and communication you will appreciate that we adhere to a code of exceptional standards and ideals established by the founders of our republic we believe they embody some of the finest virtues relating to dedication and service and are as appropriate in business today as they were nearly two centuries ago founders capital management incphone fax  post oak parkway suite houston tx grant buce grantfounderscapitalnetscott orr scottfounderscapitalnetjamie walter jwalterfounderscapitalnet   abbott laboratories nyseabt stock price news  analysis abbott laboratories company profile nyseabt company profile analyst ratings earnings history earnings estimates dividend history insider trade headlines social media chart about abbott laboratories nyseabt abbott laboratories is engaged in the discovery development manufacture and sale of a range of healthcare products the company operates through four segments established pharmaceutical products diagnostic products nutritional products and vascular products its established pharmaceutical products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the united states its diagnostic products include a range of diagnostic systems and tests its nutritional products include a range of pediatric and adult nutritional products its companys vascular products include a range of coronary endovascular vessel closure and structural heart devices for the treatment of vascular disease the company through st jude medical inc also offers products such as rhythm management products electrophysiology products heart failure related products vascular products structural heart products and neuromodulation products industry sector and symbol sector medical industry pharmaceuticals  nec subindustry health care equipment symbol nyseabt cusip  web wwwabbottcom capitalizationmarket cap  billionoutstanding shares average prices day moving avg  day moving avg  week range    petrailing pe ratio foreward pe ratio pe growth sales  book valueannual revenue  billionprice  sales book value  per shareprice  book dividendannual dividend dividend yield  profitabilityebidta  billionnet margins return on equity return on assets debtdebttoequity ratio current ratio quick ratio miscaverage volume  million shsbeta short ratio    frequently asked questions for abbott laboratories nyseabt what is abbott laboratories stock symbol abbott laboratories trades on the new york stock exchange nyse under the ticker symbol abt how often does abbott laboratories pay dividends what is the dividend yield for abbott laboratories abbott laboratories announced a quarterly dividend on friday june th shareholders of record on friday july th will be given a dividend of  per share on tuesday august th this represents a  annualized dividend and a yield of  the exdividend date is wednesday july th view abbott laboratories dividend history how were abbott laboratories earnings last quarter abbott laboratories nyseabt posted its quarterly earnings data on thursday july th the company reported  earnings per share for the quarter topping analysts consensus estimates of  by  the business had revenue of  billion for the quarter compared to the consensus estimate of  billion abbott laboratories had a net margin of  and a return on equity of  the companys quarterly revenue was up  compared to the same quarter last year during the same quarter in the prior year the firm earned  eps view abbott laboratories earnings history when will abbott laboratories make its next earnings announcement abbott laboratories is scheduled to release their next quarterly earnings announcement on tuesday october th  view earnings estimates for abbott laboratories what guidance has abbott laboratories issued on next quarters earnings abbott laboratories issued an update on its third quarter earnings guidance on thursday july th the company provided earnings per share guidance of  for the period compared to the thomson reuters consensus estimate of  abbott laboratories also updated its fy guidance to  eps where is abbott laboratories stock going where will abbott laboratories stock price be in   equities research analysts have issued  month price targets for abbott laboratories shares their forecasts range from  to  on average they anticipate abbott laboratories share price to reach  in the next year view analyst ratings for abbott laboratories what are analysts saying about abbott laboratories stock here are some recent quotes from research analysts about abbott laboratories stock  according to zacks investment research for the majority of last one month abbott is trading above the broader medical products industry we are optimistic about the company’s strong and consistent epd and medical devices performance in the last reported first quarter overall the company stands to benefit from the ongoing integration and synergy achievement of st jude we are also looking forward to the company’s plans to focus on selling portfolio in core therapeutic areas recently abbott received ce mark for its tacticath sensor and confirm rx icm products which is quite encouraging the company also launched sciencebased nutrition drinks for better recovery from surgeries on the flip side abbott’s sluggish pediatric business in china continues to hamper growth management is also concerned about the ongoing economic problem in venezuela that is expected to remain unresolved in the coming quarters   jefferies group llc analysts commented investment summary we are reiterating our overweight rating for cori and we are raising our pt by  to  following the positive donepezil patch bioequivalence results progress in the development of a proprietary pipeline is key in our opinion to the performance of the shares successful development of patch formulations of donepezil aricept andor memantine namenda should position the company well to moreeffectively monetize the transdermal drug delivery platform in our opinion retention of meaningful commercialization rights could enable the company to turn the corner and pursue other opportunities more broadly in our opinion corplex donepezil pilot study shows bioequivalence management reported that the corplex donepezil pilot study met the fda statistical criteria for bioequivalence we note too that the patch was welltolerated with good skin and gi tolerability  who are some of abbott laboratories key competitors some companies that are related to abbott laboratories include merck  company mrk sanofi sny novo nordisk as nvo glaxosmithkline plc gsk bristolmyers squibb company bmy eli lilly and company lly astrazeneca plc azn glaxosmithkline plc gsk astrazeneca plc azn shire plc shpg shire plc shp teva pharmaceutical industries limited teva dr reddys laboratories ltd rdy valeant pharmaceuticals international vrx patheon nv pthn taro pharmaceutical industries taro catalent ctlt and akorn akrx who are abbott laboratories key executives abbott laboratories management team includes the folowing people miles d white chairman of the board chief executive officerbrian b yoor chief financial officer senior vice president  financemichael t rousseau president  cardiovascular and neuromodulationhubert l allen executive vice president general counsel secretarystephen r fussell executive vice president  human resourcesbrian j blaser executive vice president  diagnostics productsjohn m capek phd executive vice president  venturesrobert b ford executive vice president  medical devicesheather l mason executive vice president  nutritional productsroger bird senior vice president  us nutrition who owns abbott laboratories stock abbott laboratories stock is owned by a variety of of institutional and retail investors top institutional shareholders include flossbach von storch ag  diamond hill capital management inc  independent franchise partners llp  vontobel asset management inc  us bancorp de  and rockefeller financial services inc  company insiders that own abbott laboratories stock include brian b yoor brian j blaser daniel gesua sive salvadori deepak s nath heather l mason hubert l allen jaime contreras jared watkin joseph j manning michael j warmuth miles d white robert b ford robert e funck roger bird sally e blount and stephen r fussell view institutional ownership trends for abbott laboratories who sold abbott laboratories stock who is selling abbott laboratories stock abbott laboratories stock was sold by a variety of institutional investors in the last quarter including dnb asset management as state of new jersey common pension fund d apg asset management nv rothschild asset management inc bank of montreal can diamond hill capital management inc vontobel asset management inc and locust wood capital advisers llc company insiders that have sold abbott laboratories stock in the last year include daniel gesua sive salvadori deepak s nath heather l mason hubert l allen jared watkin joseph j manning michael j warmuth robert e funck roger bird and stephen r fussell view insider buying and selling for abbott laboratories who bought abbott laboratories stock who is buying abbott laboratories stock abbott laboratories stock was purchased by a variety of institutional investors in the last quarter including hexavest inc fisher asset management llc mn services vermogensbeheer bv national pension service pennsylvania trust co aperio group llc harbour capital advisors llc and independent franchise partners llp company insiders that have bought abbott laboratories stock in the last two years include brian j blaser miles d white robert b ford and sally e blount view insider buying and selling for abbott laboratories how do i buy abbott laboratories stock shares of abbott laboratories can be purchased through any online brokerage account popular online brokerages include vanguard brokerage services td ameritrade etrade scottrade fidelity and charles schwab what is abbott laboratories stock price today one share of abbott laboratories stock can currently be purchased for approximately  marketbeat community rating for abbott laboratories nyse abtcommunity ranking   out of   outperform votes   vote outperformunderperform votes   vote underperformtotal votes  marketbeats community ratings are surveys of what our community members think about abbott laboratories and other stocks vote outperform if you believe the stock will outperform the sp  over the long term vote underperform if you believe the stock will underperform the sp  over the long term you may vote once every thirty days analyst ratings consensus ratings for abbott laboratories nyseabt how are consensus ratings calculated marketbeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months since brokers often use different ratings systems each rating is normalized to a standardized rating score of  sell  hold  buy or  strong buy consensus ratings scores are calculated using the mean average of the number of normalized sell hold buy and strong buy ratings each stocks consensus rating is derived from its calculated consensus ratings score   sell   hold   buy   strong buy marketbeats consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve monthsmarketbeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and marketbeat has received a report that coverage was dropped ratings from certain research firms that issue ratings using purely quantitative methods such as zacks vetr and valuengine are not included in consensus calculations marketbeats consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available dataratings breakdown  hold ratings  buy ratingsconsensus ratingbuy score consensus price target   upside analysts ratings history for abbott laboratories nyseabt show only the most recent rating from each brokerage all ratings for this stock datefirmactionratingprice targetimpact on share pricedetailsbarclays plcreiterated ratingoverweight  lowstifel nicolausreiterated ratingbuylowcowen and companyreiterated ratingoutperform  lowbmo capital marketsreiterated ratingholdlowmorgan stanleyreiterated ratingequal weightlowwells fargo  companyreiterated ratingoutperform  lowjefferies group llcreiterated ratingbuylowguggenheiminitiated coveragebuylowbtig researchinitiated coveragebuylowgoldman sachs group inc theinitiated coverageneutral  neutrallowroyal bank of canadareiterated ratingbuylowbank of america corporationreiterated ratingbuynadeutsche bank agreiterated ratingbuynaargusreiterated ratingbuynaedward jonesupgradehold  buynacredit suisse groupreiterated ratingbuynasp equity researchreiterated ratingholdnagabellireiterated ratingbuynapiper jaffray companiesdowngradeoverweight  neutralnafirst globaldowngradeoutperform  marketperformnaleerink swannboost price targetmarket perform  naraymond james financial inclower price targetoutperform  nawilliam blairdowngradeoutperform  market performnadata available from  forward earnings earnings history for abbott laboratories nyseabtearnings history by quarter for abbott laboratories nyse abtdatequarterconsensus estimateactual epsrevenue estimateactual revenuerelease linkconference calldetailsnaq  billion billionviewna billion billionviewnaq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq  billion billionviewlistenq  billion billionviewlistenq  billion billionviewlistenviewnaviewnaviewnaviewnaviewnaviewnaviewnaviewnadata available from  forward estimates earnings estimates for abbott laboratories nyseabt eps consensus estimate  eps consensus estimate quarternumber of estimateslow estimatehigh estimateaverage estimateq q q q q q q q data provided by zacks investment research dividends current dividend information for abbott laboratories nyseabtnext dividendannual dividenddividend yielddividend growth  year averagepayout ratio trailing  months of earnings  based on this years estimates based on next years estimatestrack record years of consecutive dividend growthdividend history by quarter for abbott laboratories nyse abtannouncedperiodamountyieldexdividend daterecord datepayable datequarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlydata available from  forward insider trades insider trading and institutional ownership history for abbott laboratories nyseabtinsider ownership percentage institutional ownership percentage insider trades by quarter for abbott laboratories nyseabttransaction dateinsider nametitlebuysellnumber of sharesaverage share pricetotal transactiondetailshubert l alleninsidersell  jared watkininsidersell  stephen r fussellinsidersell  roger birdinsidersell  joseph j manninginsidersell  michael j warmuthinsidersell  robert e funckvpsell  roger birdinsidersell  deepak s nathinsidersell  heather l masoninsidersell  brian j blaserinsiderbuy  robert b fordinsiderbuy  miles d whitechairmanbuy  sally e blountdirectorbuy  daniel gesua sive salvadorisvpsell  stephen r fussellinsidersell  michael j warmuthinsidersell  miles d whitechairmanbuy  robert e funckvpsell  hubert l allenevpsell  jared watkinsvpsell  brian b yoorcfosell  deepak s nathsvpsell  jaime contrerassvpsell  brian b yoorcfosell  deepak s nathsvpsell  robert b fordevpsell  robert e funckvpsell  jared watkinsvpsell  deepak s nathsvpsell  miles d whiteceosell  stephen r fussellevpsell  heather l masonevpsell  roger birdsvpsell  j scott whitesvpsell  jaime contrerassvpsell  john m capekevpsell  jaime contrerassvpsell  miles d whiteceosell  john landgrafevpsell  katherine doylesvpsell  robert funckvpsell  john landgrafevpsell  michael warmuthevpsell  jeanyves paveesvpsell  stephen fussellevpsell  jaime contrerassvpsell  heather l masonsvpsell  william a osborndirectorbuy  data available from  forward headlines headline trends for abbott laboratories nyseabt latest headlines for abbott laboratories nyseabt source all sources trusted sources marketbeatcom bloomberg marketwatch motley fool nasdaq reuters seeking alpha the street the wall street journal yahoo finance dateheadlineabbott laboratories nyseabt insider sells  in stockwwwamericanbankingnewscom  july  at  pmbreakfast technical briefing on medical equipment stocks  abbott labs boston scientific medtronic and mimedxwwwbizjournalscom  july  at  pmbuying abbott near its peak  seeking alphaseekingalphacom  july  at  pmanalysts raise recommendations on abbott stock after qfinanceyahoocom  july  at  pmthe zacks analyst blog highlights oracle pfizer abbott alphabet and schlumbergerfinanceyahoocom  july  at  pmstrong q results trigger rise in abbott stockfinanceyahoocom  july  at  pmabbott laboratories’ q results which segment fared bestfinanceyahoocom  july  at  pmwhat were abbott’s key growth drivers for qfinanceyahoocom  july  at  pma review of the dividend house portfolio time for a house inspectionseekingalphacom  july  at  pmabiomed expects to expand its presence in this spacefinanceyahoocom  july  at  pmfy earnings estimate for abbott laboratories abt issued by gabelliwwwamericanbankingnewscom  july  at  amabbott laboratories expected to post fy earnings of  per share nyseabtwwwamericanbankingnewscom  july  at  amfy earnings estimate for abbott laboratories abt issued by william blairwwwamericanbankingnewscom  july  at  amjefferies group comments on abbott laboratories q  earnings abtwwwamericanbankingnewscom  july  at  amabbott laboratories nyseabt expected to post quarterly sales of  billionwwwamericanbankingnewscom  july  at  pmabbott laboratories abt overweight rating reaffirmed at barclays plcwwwamericanbankingnewscom  july  at  pmabbott labs abt pt raised to  at argus on q beat  fy raise positive view of growth prospects  streetinsidercomwwwstreetinsidercom  july  at  pmabbott labs abt pt raised to  at barclays on q beat  fy eps raise h outlook appears bright  streetinsidercomwwwstreetinsidercom  july  at  pmabbott laboratories abt buy rating reaffirmed at stifel nicolauswwwamericanbankingnewscom  july  at  pmtodays research reports on stocks to watch abbott laboratories and pfizer incfinanceyahoocom  july  at  pmcompany news for july  financeyahoocom  july  at  pmbehind the major drivers of jnj’s medical device growthfinanceyahoocom  july  at  pmabbott laboratories nyseabt price target raised to  at arguswwwamericanbankingnewscom  july  at  pmdeutsche bank ag increases abbott laboratories abt price target to wwwamericanbankingnewscom  july  at  pmzacks brokerages anticipate abbott laboratories nyseabt to announce  epswwwamericanbankingnewscom  july  at  amabbott q profit falls but results top view lifts  profit outlookwwwrttnewscom  july  at  amlabcorp lh q earnings is disappointment in the cardsfinanceyahoocom  july  at  pmabbott laboratories abt releases q earnings guidancewwwamericanbankingnewscom  july  at  pmabbott labs abt beats on q earnings and sales view up  nasdaqwwwnasdaqcom  july  at  pmabbott abt tops earnings estimates in q misses on salesfinanceyahoocom  july  at  pmus stockswall st flat as earnings from some big names disappointfinanceyahoocom  july  at  pmabbott zeros in on a year high after topping q sales profitsfinanceyahoocom  july  at  pmus stockswall st flat as consumer stocks weak earnings weighfinanceyahoocom  july  at  pmabbott ceo another alererelated divestiture coming soonfinanceyahoocom  july  at  pmabbott labs abt beats on q earnings and sales view upfinanceyahoocom  july  at  pmabbott profit forecast gets a lift from st jude integrationfinanceyahoocom  july  at  pmabbott tops street q forecastsfinanceyahoocom  july  at  pmus stockssp dow flat as retailers weigh nasdaq edges higherfinanceyahoocom  july  at  pmabbott laboratories abt releases earnings resultswwwamericanbankingnewscom  july  at  amabbott laboratories abt releases fy earnings guidancewwwamericanbankingnewscom  july  at  amwhat to watch for in abbotts q earnings  nasdaqwwwnasdaqcom  july  at  pmmedical product stocks earnings on jul  abt isrg  more  nasdaqwwwnasdaqcom  july  at  pmabbott laboratories nyseabt american express company   benzingawwwbenzingacom  july  at  pmquidel diversifies with aleres triage assets  thestreetcomwwwthestreetcom  july  at  pmquidel diversifies with aleres triage assetsfinanceyahoocom  july  at  pmrisk arbitrage today  ma deals that had price cuts with a little meat left on the boneseekingalphacom  july  at  pmabbotts tarnished deal sparkles for anotherfinanceyahoocom  july  at  pmcan abbott laboratories abt pull a surprise in q earnings  nasdaqwwwnasdaqcom  july  at  amcan abbott laboratories abt pull a surprise in q earningsfinanceyahoocom  july  at  pmearnings roundup jnj ibm and lmt report q results tomorrow  benzingawwwbenzingacom  july  at  pm social chart abbott laboratories abt chart for friday july   this page was last updated on  by marketbeatcom staff founders capital management founders capital management schwab alliance approach case studies research  annual letters team contact   investing for the long term every day we are an innovative money management firm with a deep understanding of business management and capital allocation home  sitemap  terms of use  privacy policy    founders capital management all rights reserved founders capital management llc  wealthminder founders capital management llc founders capital management llc crd  is a financial advisory firm headquartered in east hartford ct they manage  in  accounts and serve the financial needs of clients across  states or territories current firm details founders capital management llc  founders plaza suite  east hartford ct   httpwwwfoundcapitalcom httpwwwfoundcapitalcom by the numbers total assets under management  million total number of accounts  accounts average account value  compensation options a percentage of assets under your management advisory services offered portfolio management for individuals andor small businesses portfolio management for businesses other than small businesses or institutional clients types of clients registered states registered investment advisor advisors affiliated with a ria are permitted to work with up to five clients in nearlyall states without explicit registration the map below shows states where this firm has explicit registration only ca ct fl ma ny financial advisors at founders capital management llc showing    of  top financial advisors  howard e case crd   founders plaza suite  east hartford ct   wealthminder score howard case crd  is an investment advisor representative working at founders capital management llc in east hartford ct and has over  years of experience in the finance industry  jon m case crd   founders plaza suite  east hartford ct   wealthminder score jon case crd  is an investment advisor representative working at founders capital management llc in east hartford ct and has over  years of experience in the finance industry  patrick a terrion crd   founders plaza suite  east hartford ct   wealthminder score patrick terrion crd  is an investment advisor representative working at founders capital management llc in east hartford ct and has over  years of experience in the finance industry our primary data source is public filings of form adv as published by the securities and exchange commission sec and made available in accordance with the freedom of information act foia supplementary information may be provided by listed advisors or their representatives because many firms provide a variety of products or services an individual may or may not be registered to operate under all services provided by the firmdo not rely solely on the information on this page the information may be inaccurate incomplete or outdated for the most accurate and uptodate information please search for the firm or individual on the sec site at httpwwwadviserinfosecgoviapdcontentsearchiapdsearchaspx ready to hire a financial advisor get competitive proposals from multiple advisors request proposals timeout you have been idle and will be logged out in seconds stay logged in log out now abbott laboratories nyseabt stock price news  analysis abbott laboratories company profile nyseabt company profile analyst ratings earnings history earnings estimates dividend history insider trade headlines social media chart about abbott laboratories nyseabt abbott laboratories is engaged in the discovery development manufacture and sale of a range of healthcare products the company operates through four segments established pharmaceutical products diagnostic products nutritional products and vascular products its established pharmaceutical products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the united states its diagnostic products include a range of diagnostic systems and tests its nutritional products include a range of pediatric and adult nutritional products its companys vascular products include a range of coronary endovascular vessel closure and structural heart devices for the treatment of vascular disease the company through st jude medical inc also offers products such as rhythm management products electrophysiology products heart failure related products vascular products structural heart products and neuromodulation products industry sector and symbol sector medical industry pharmaceuticals  nec subindustry health care equipment symbol nyseabt cusip  web wwwabbottcom capitalizationmarket cap  billionoutstanding shares average prices day moving avg  day moving avg  week range    petrailing pe ratio foreward pe ratio pe growth sales  book valueannual revenue  billionprice  sales book value  per shareprice  book dividendannual dividend dividend yield  profitabilityebidta  billionnet margins return on equity return on assets debtdebttoequity ratio current ratio quick ratio miscaverage volume  million shsbeta short ratio    frequently asked questions for abbott laboratories nyseabt what is abbott laboratories stock symbol abbott laboratories trades on the new york stock exchange nyse under the ticker symbol abt how often does abbott laboratories pay dividends what is the dividend yield for abbott laboratories abbott laboratories announced a quarterly dividend on friday june th shareholders of record on friday july th will be given a dividend of  per share on tuesday august th this represents a  annualized dividend and a yield of  the exdividend date is wednesday july th view abbott laboratories dividend history how were abbott laboratories earnings last quarter abbott laboratories nyseabt posted its quarterly earnings data on thursday july th the company reported  earnings per share for the quarter topping analysts consensus estimates of  by  the business had revenue of  billion for the quarter compared to the consensus estimate of  billion abbott laboratories had a net margin of  and a return on equity of  the companys quarterly revenue was up  compared to the same quarter last year during the same quarter in the prior year the firm earned  eps view abbott laboratories earnings history when will abbott laboratories make its next earnings announcement abbott laboratories is scheduled to release their next quarterly earnings announcement on tuesday october th  view earnings estimates for abbott laboratories what guidance has abbott laboratories issued on next quarters earnings abbott laboratories issued an update on its third quarter earnings guidance on thursday july th the company provided earnings per share guidance of  for the period compared to the thomson reuters consensus estimate of  abbott laboratories also updated its fy guidance to  eps where is abbott laboratories stock going where will abbott laboratories stock price be in   equities research analysts have issued  month price targets for abbott laboratories shares their forecasts range from  to  on average they anticipate abbott laboratories share price to reach  in the next year view analyst ratings for abbott laboratories what are analysts saying about abbott laboratories stock here are some recent quotes from research analysts about abbott laboratories stock  according to zacks investment research for the majority of last one month abbott is trading above the broader medical products industry we are optimistic about the company’s strong and consistent epd and medical devices performance in the last reported first quarter overall the company stands to benefit from the ongoing integration and synergy achievement of st jude we are also looking forward to the company’s plans to focus on selling portfolio in core therapeutic areas recently abbott received ce mark for its tacticath sensor and confirm rx icm products which is quite encouraging the company also launched sciencebased nutrition drinks for better recovery from surgeries on the flip side abbott’s sluggish pediatric business in china continues to hamper growth management is also concerned about the ongoing economic problem in venezuela that is expected to remain unresolved in the coming quarters   jefferies group llc analysts commented investment summary we are reiterating our overweight rating for cori and we are raising our pt by  to  following the positive donepezil patch bioequivalence results progress in the development of a proprietary pipeline is key in our opinion to the performance of the shares successful development of patch formulations of donepezil aricept andor memantine namenda should position the company well to moreeffectively monetize the transdermal drug delivery platform in our opinion retention of meaningful commercialization rights could enable the company to turn the corner and pursue other opportunities more broadly in our opinion corplex donepezil pilot study shows bioequivalence management reported that the corplex donepezil pilot study met the fda statistical criteria for bioequivalence we note too that the patch was welltolerated with good skin and gi tolerability  who are some of abbott laboratories key competitors some companies that are related to abbott laboratories include merck  company mrk sanofi sny novo nordisk as nvo glaxosmithkline plc gsk bristolmyers squibb company bmy eli lilly and company lly astrazeneca plc azn glaxosmithkline plc gsk astrazeneca plc azn shire plc shpg shire plc shp teva pharmaceutical industries limited teva dr reddys laboratories ltd rdy valeant pharmaceuticals international vrx patheon nv pthn taro pharmaceutical industries taro catalent ctlt and akorn akrx who are abbott laboratories key executives abbott laboratories management team includes the folowing people miles d white chairman of the board chief executive officerbrian b yoor chief financial officer senior vice president  financemichael t rousseau president  cardiovascular and neuromodulationhubert l allen executive vice president general counsel secretarystephen r fussell executive vice president  human resourcesbrian j blaser executive vice president  diagnostics productsjohn m capek phd executive vice president  venturesrobert b ford executive vice president  medical devicesheather l mason executive vice president  nutritional productsroger bird senior vice president  us nutrition who owns abbott laboratories stock abbott laboratories stock is owned by a variety of of institutional and retail investors top institutional shareholders include flossbach von storch ag  diamond hill capital management inc  independent franchise partners llp  vontobel asset management inc  us bancorp de  and rockefeller financial services inc  company insiders that own abbott laboratories stock include brian b yoor brian j blaser daniel gesua sive salvadori deepak s nath heather l mason hubert l allen jaime contreras jared watkin joseph j manning michael j warmuth miles d white robert b ford robert e funck roger bird sally e blount and stephen r fussell view institutional ownership trends for abbott laboratories who sold abbott laboratories stock who is selling abbott laboratories stock abbott laboratories stock was sold by a variety of institutional investors in the last quarter including dnb asset management as state of new jersey common pension fund d apg asset management nv rothschild asset management inc bank of montreal can diamond hill capital management inc vontobel asset management inc and locust wood capital advisers llc company insiders that have sold abbott laboratories stock in the last year include daniel gesua sive salvadori deepak s nath heather l mason hubert l allen jared watkin joseph j manning michael j warmuth robert e funck roger bird and stephen r fussell view insider buying and selling for abbott laboratories who bought abbott laboratories stock who is buying abbott laboratories stock abbott laboratories stock was purchased by a variety of institutional investors in the last quarter including hexavest inc fisher asset management llc mn services vermogensbeheer bv national pension service pennsylvania trust co aperio group llc harbour capital advisors llc and independent franchise partners llp company insiders that have bought abbott laboratories stock in the last two years include brian j blaser miles d white robert b ford and sally e blount view insider buying and selling for abbott laboratories how do i buy abbott laboratories stock shares of abbott laboratories can be purchased through any online brokerage account popular online brokerages include vanguard brokerage services td ameritrade etrade scottrade fidelity and charles schwab what is abbott laboratories stock price today one share of abbott laboratories stock can currently be purchased for approximately  marketbeat community rating for abbott laboratories nyse abtcommunity ranking   out of   outperform votes   vote outperformunderperform votes   vote underperformtotal votes  marketbeats community ratings are surveys of what our community members think about abbott laboratories and other stocks vote outperform if you believe the stock will outperform the sp  over the long term vote underperform if you believe the stock will underperform the sp  over the long term you may vote once every thirty days analyst ratings consensus ratings for abbott laboratories nyseabt how are consensus ratings calculated marketbeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months since brokers often use different ratings systems each rating is normalized to a standardized rating score of  sell  hold  buy or  strong buy consensus ratings scores are calculated using the mean average of the number of normalized sell hold buy and strong buy ratings each stocks consensus rating is derived from its calculated consensus ratings score   sell   hold   buy   strong buy marketbeats consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve monthsmarketbeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and marketbeat has received a report that coverage was dropped ratings from certain research firms that issue ratings using purely quantitative methods such as zacks vetr and valuengine are not included in consensus calculations marketbeats consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available dataratings breakdown  hold ratings  buy ratingsconsensus ratingbuy score consensus price target   upside analysts ratings history for abbott laboratories nyseabt show only the most recent rating from each brokerage all ratings for this stock datefirmactionratingprice targetimpact on share pricedetailsbarclays plcreiterated ratingoverweight  lowstifel nicolausreiterated ratingbuylowcowen and companyreiterated ratingoutperform  lowbmo capital marketsreiterated ratingholdlowmorgan stanleyreiterated ratingequal weightlowwells fargo  companyreiterated ratingoutperform  lowjefferies group llcreiterated ratingbuylowguggenheiminitiated coveragebuylowbtig researchinitiated coveragebuylowgoldman sachs group inc theinitiated coverageneutral  neutrallowroyal bank of canadareiterated ratingbuylowbank of america corporationreiterated ratingbuynadeutsche bank agreiterated ratingbuynaargusreiterated ratingbuynaedward jonesupgradehold  buynacredit suisse groupreiterated ratingbuynasp equity researchreiterated ratingholdnagabellireiterated ratingbuynapiper jaffray companiesdowngradeoverweight  neutralnafirst globaldowngradeoutperform  marketperformnaleerink swannboost price targetmarket perform  naraymond james financial inclower price targetoutperform  nawilliam blairdowngradeoutperform  market performnadata available from  forward earnings earnings history for abbott laboratories nyseabtearnings history by quarter for abbott laboratories nyse abtdatequarterconsensus estimateactual epsrevenue estimateactual revenuerelease linkconference calldetailsnaq  billion billionviewna billion billionviewnaq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq billion billionviewlistenq  billion billionviewlistenq  billion billionviewlistenq  billion billionviewlistenviewnaviewnaviewnaviewnaviewnaviewnaviewnaviewnadata available from  forward estimates earnings estimates for abbott laboratories nyseabt eps consensus estimate  eps consensus estimate quarternumber of estimateslow estimatehigh estimateaverage estimateq q q q q q q q data provided by zacks investment research dividends current dividend information for abbott laboratories nyseabtnext dividendannual dividenddividend yielddividend growth  year averagepayout ratio trailing  months of earnings  based on this years estimates based on next years estimatestrack record years of consecutive dividend growthdividend history by quarter for abbott laboratories nyse abtannouncedperiodamountyieldexdividend daterecord datepayable datequarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlyquarterlydata available from  forward insider trades insider trading and institutional ownership history for abbott laboratories nyseabtinsider ownership percentage institutional ownership percentage insider trades by quarter for abbott laboratories nyseabttransaction dateinsider nametitlebuysellnumber of sharesaverage share pricetotal transactiondetailshubert l alleninsidersell  jared watkininsidersell  stephen r fussellinsidersell  roger birdinsidersell  joseph j manninginsidersell  michael j warmuthinsidersell  robert e funckvpsell  roger birdinsidersell  deepak s nathinsidersell  heather l masoninsidersell  brian j blaserinsiderbuy  robert b fordinsiderbuy  miles d whitechairmanbuy  sally e blountdirectorbuy  daniel gesua sive salvadorisvpsell  stephen r fussellinsidersell  michael j warmuthinsidersell  miles d whitechairmanbuy  robert e funckvpsell  hubert l allenevpsell  jared watkinsvpsell  brian b yoorcfosell  deepak s nathsvpsell  jaime contrerassvpsell  brian b yoorcfosell  deepak s nathsvpsell  robert b fordevpsell  robert e funckvpsell  jared watkinsvpsell  deepak s nathsvpsell  miles d whiteceosell  stephen r fussellevpsell  heather l masonevpsell  roger birdsvpsell  j scott whitesvpsell  jaime contrerassvpsell  john m capekevpsell  jaime contrerassvpsell  miles d whiteceosell  john landgrafevpsell  katherine doylesvpsell  robert funckvpsell  john landgrafevpsell  michael warmuthevpsell  jeanyves paveesvpsell  stephen fussellevpsell  jaime contrerassvpsell  heather l masonsvpsell  william a osborndirectorbuy  data available from  forward headlines headline trends for abbott laboratories nyseabt latest headlines for abbott laboratories nyseabt source all sources trusted sources marketbeatcom bloomberg marketwatch motley fool nasdaq reuters seeking alpha the street the wall street journal yahoo finance dateheadlineabbott laboratories nyseabt insider sells  in stockwwwamericanbankingnewscom  july  at  pmbreakfast technical briefing on medical equipment stocks  abbott labs boston scientific medtronic and mimedxwwwbizjournalscom  july  at  pmbuying abbott near its peak  seeking alphaseekingalphacom  july  at  pmanalysts raise recommendations on abbott stock after qfinanceyahoocom  july  at  pmthe zacks analyst blog highlights oracle pfizer abbott alphabet and schlumbergerfinanceyahoocom  july  at  pmstrong q results trigger rise in abbott stockfinanceyahoocom  july  at  pmabbott laboratories’ q results which segment fared bestfinanceyahoocom  july  at  pmwhat were abbott’s key growth drivers for qfinanceyahoocom  july  at  pma review of the dividend house portfolio time for a house inspectionseekingalphacom  july  at  pmabiomed expects to expand its presence in this spacefinanceyahoocom  july  at  pmfy earnings estimate for abbott laboratories abt issued by gabelliwwwamericanbankingnewscom  july  at  amabbott laboratories expected to post fy earnings of  per share nyseabtwwwamericanbankingnewscom  july  at  amfy earnings estimate for abbott laboratories abt issued by william blairwwwamericanbankingnewscom  july  at  amjefferies group comments on abbott laboratories q  earnings abtwwwamericanbankingnewscom  july  at  amabbott laboratories nyseabt expected to post quarterly sales of  billionwwwamericanbankingnewscom  july  at  pmabbott laboratories abt overweight rating reaffirmed at barclays plcwwwamericanbankingnewscom  july  at  pmabbott labs abt pt raised to  at argus on q beat  fy raise positive view of growth prospects  streetinsidercomwwwstreetinsidercom  july  at  pmabbott labs abt pt raised to  at barclays on q beat  fy eps raise h outlook appears bright  streetinsidercomwwwstreetinsidercom  july  at  pmabbott laboratories abt buy rating reaffirmed at stifel nicolauswwwamericanbankingnewscom  july  at  pmtodays research reports on stocks to watch abbott laboratories and pfizer incfinanceyahoocom  july  at  pmcompany news for july  financeyahoocom  july  at  pmbehind the major drivers of jnj’s medical device growthfinanceyahoocom  july  at  pmabbott laboratories nyseabt price target raised to  at arguswwwamericanbankingnewscom  july  at  pmdeutsche bank ag increases abbott laboratories abt price target to wwwamericanbankingnewscom  july  at  pmzacks brokerages anticipate abbott laboratories nyseabt to announce  epswwwamericanbankingnewscom  july  at  amabbott q profit falls but results top view lifts  profit outlookwwwrttnewscom  july  at  amlabcorp lh q earnings is disappointment in the cardsfinanceyahoocom  july  at  pmabbott laboratories abt releases q earnings guidancewwwamericanbankingnewscom  july  at  pmabbott labs abt beats on q earnings and sales view up  nasdaqwwwnasdaqcom  july  at  pmabbott abt tops earnings estimates in q misses on salesfinanceyahoocom  july  at  pmus stockswall st flat as earnings from some big names disappointfinanceyahoocom  july  at  pmabbott zeros in on a year high after topping q sales profitsfinanceyahoocom  july  at  pmus stockswall st flat as consumer stocks weak earnings weighfinanceyahoocom  july  at  pmabbott ceo another alererelated divestiture coming soonfinanceyahoocom  july  at  pmabbott labs abt beats on q earnings and sales view upfinanceyahoocom  july  at  pmabbott profit forecast gets a lift from st jude integrationfinanceyahoocom  july  at  pmabbott tops street q forecastsfinanceyahoocom  july  at  pmus stockssp dow flat as retailers weigh nasdaq edges higherfinanceyahoocom  july  at  pmabbott laboratories abt releases earnings resultswwwamericanbankingnewscom  july  at  amabbott laboratories abt releases fy earnings guidancewwwamericanbankingnewscom  july  at  amwhat to watch for in abbotts q earnings  nasdaqwwwnasdaqcom  july  at  pmmedical product stocks earnings on jul  abt isrg  more  nasdaqwwwnasdaqcom  july  at  pmabbott laboratories nyseabt american express company   benzingawwwbenzingacom  july  at  pmquidel diversifies with aleres triage assets  thestreetcomwwwthestreetcom  july  at  pmquidel diversifies with aleres triage assetsfinanceyahoocom  july  at  pmrisk arbitrage today  ma deals that had price cuts with a little meat left on the boneseekingalphacom  july  at  pmabbotts tarnished deal sparkles for anotherfinanceyahoocom  july  at  pmcan abbott laboratories abt pull a surprise in q earnings  nasdaqwwwnasdaqcom  july  at  amcan abbott laboratories abt pull a surprise in q earningsfinanceyahoocom  july  at  pmearnings roundup jnj ibm and lmt report q results tomorrow  benzingawwwbenzingacom  july  at  pm social chart abbott laboratories abt chart for friday july   this page was last updated on  by marketbeatcom staff founders capital management llc buys baker hughes inc unitedhealth group inc sells gilead   good medical infertility headaches fatigue brain diseases alzheimer’s disease parkinson’s disease bronchitis vaccines flu vaccines mumps vaccines cannabis cancer bladder cancer brain cancer rare disease bloom syndrome duchenne muscular dystrophy‬‬ genetic disorder methamphetamine search sign in welcome log into your account your username your password forgot your password get help password recovery recover your password your email a password will be emailed to you good medical infertility treat infertility with the various options available men’s sperm counts are dropping worldwide study why organics are no longer an option mac cheese and hot lead real stories from couples that had a hard time trying to… headaches sinus infection symptoms headache and migraine relief – causes and solutions say bye to headaches with migrelief migraine cure – a migraine headache treatment that works well warning symptoms and signs of liver cancer fatigue what is functional and integrative medicine what is lymphatic cancer health problems related to office work sleep apnea – the silent sleep disorder anxiety and anxiety attacks brain diseases allalzheimer’s diseaseparkinson’s disease new method may help distinguish frontotemporal dementia from alzheimer’s disease being neurotic might help you live longer why do we need special nursing homes for people with dementia  in  cases of dementia could be prevented by healthier… bronchitis licorice from himalaya – alternative medicine for cough  ulcer the detection of asthma with chest xrays magnesium chloride for health and rejuvenation the most common types of lung diseases signs or symptoms of acute bronchitis vaccines allflu vaccinesmumps vaccines angelina jolie diagnosed with bell’s palsy—what is it influenza vaccine linked to less hospitalizations among elderly sri lanka dengue outbreak kills  hospitals on the brink just a few vaccine refusers could endanger many cannabis nsa officer talk show host turns cannabis entrepreneur cannabis deserts  cannabis now maryland’s top court hears case on medical marijuana growers’ dispute sessions vs the senate committee votes to uphold mmj protections alert patients and consumers of washington state give the lcb your… cancer allbladder cancerbrain cancer mccain votes no dealing potential death blow to republican health care… obamacare repeal mcconnell releases senate ‘skinny’ bill diverse approaches needed to further advance bladder cancer care apolo talks progress future of immunotherapy in bladder cancer rare disease allbloom syndromeduchenne muscular dystrophy‬‬genetic disordermethamphetamine methamphetamine lab found in bella vista microdystrophin gene therapy shows promise in dogs with dmd crosscountry bicyclists stop in west hempfield as they raise awareness about… gene therapy reverses muscular dystrophy symptoms in dogs home health care companies unitedhealth group founders capital management llc buys baker hughes inc unitedhealth group inc sells health care companiesunitedhealth group founders capital management llc buys baker hughes inc unitedhealth group inc sells gilead … by nicolas  july     share on facebook tweet on twitter founders capital management llc new purchases bhi  unh  reduced positions pg  sold outgild bhge for the details of founders capital management llc’s stock buys and sells go to httpwwwgurufocuscomstockbuyphpgurunamefounderscapitalmanagementcllc these are the top  holdings of founders capital management llc berkshire hathaway inc brkb –  shares  of the total portfolio csx corp  csx  –  shares  of the total portfolio pepsico inc  pep  –  shares  of the total portfolio intel corp  intc  –  shares  of the total portfolio att inc  t  –  shares  of the total portfolio new purchase unitedhealth group inc  unh  founders capital management llc initiated holdings in unitedhealth group inc the purchase prices were between  and  with an estimated average price of  the stock is now traded at around  the impact to the portfolio due to this purchase was  the holdings were  shares as of  new purchase baker hughes inc bhi founders capital management llc initiated holdings in baker hughes inc the purchase prices were between  and  with an estimated average price of  the stock is now traded at around  the impact to the portfolio due to this purchase was  the holdings were  shares as of  sold out gilead sciences inc gild founders capital management llc sold out the holdings in gilead sciences inc the sale prices were between  and  with an estimated average price of  sold out baker hughes a ge co bhge founders capital management llc sold out the holdings in baker hughes a ge co the sale prices were between  and  with an estimated average price of  premium members this article first appeared on gurufocus  the views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of nasdaq inc share thisclick to share on twitter opens in new windowclick to share on facebook opens in new windowclick to share on google opens in new window related related articlesmore from author neuburgh advisers llc buys  shares of unitedhealth group incorporated unh lgt capital partners ltd buys dr pepper snapple group inc unitedhealth group inc starbucks … meag munich ergo kapitalanlagegesellschaft mbh buys unitedhealth group inc micron technology … jul   – meag munich ergo kapitalanlagegesellschaft mbh buys unitedhealth group inc micron technology inc cocacola co sells ubs group ag cisco systems capital management corp va has  position in unitedhealth group incorporated nyseunh unitedhealth group incorporated nyseunh shares bought by  capital llc leave a reply cancel reply notify me of followup comments by email notify me of new posts by email top popular దగ్గు వెంటనే తగ్గాలంటేi home remedies for cough i daggu i telugu ◉ treating your migraine asmr roleplay ◉ وصفة خطيرة للعقم و نقص البويضات عند المرأة  نصائح cure asthma  bronchitis  ठीक करें asthma  bronchitis just just say no to the flu vaccine ♫♫♫  breakthrough in advanced kidney disease by stem cell genetic med health news to inspire your well beingcontact us contactgoodmedicalcom   good medical cookie consent script